Are you looking for a pharma job in the UK? In this article, we’ve put together a list of the best pharma organisations to ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance and Clinical Laboratory Improvement Amendments of 1988 (CLIA) waiver ...

LAS VEGAS, NV / ACCESS Newswire / January 23, 2025 / Skinvisible Pharmaceuticals, Inc. ("Skinvisible" or "the Company"), (OTCQB:SKVI), an innovative topical and transdermal pharmaceutical research and ...

Black Book Research Shares Key Insights and Recognizes Top 21 Vendors Advancing Diversity, Equity, and Inclusion TAMPA, ...

Revenue for 2024 expected to be up 31%Lower cost base going into 2025 with a growing sales pipeline of opportunities GUILDFORD, SURREY / ACCESS Newswire / January 23, 2025 / ANGLE plc ...

CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Press releaseAd hoc announcement pursuant to Art. 53 LRGalenica ...

VANCOUVER, BC / ACCESS Newswire / January 22, 2025 / Onco-Innovations Limited (CSE:ONCO)(Frankfurt:W1H, WKN:A3EKSZ)("Onco" or the "Company") is pleased to announce that it has entered into a letter of ...

TAMPA, FLORIDA / ACCESS Newswire / January 22, 2025 / Netsmart has once again been recognized as the top-rated provider of Electronic Health Record (EHR) and Practice Management (PM) solutions for ...

Valid Therapeutics and Araceli Biosciences Partner to Advance AI-Driven Drug Discovery NATICK, Mass., January 22, 2025 (Newswire.com) - VALID, a Techbio startup dedicated to reshaping drug discovery ...

The Centers for Medicare & Medicaid Services (CMS) has announced an additional 15 drugs that will be subject to price controls under the Inflation Reduction Act (IRA). This expansion continues a ...

CHICAGO, IL / ACCESS Newswire / January 22, 2025 / Cosmos Health Inc. ("Cosmos Health" or the "Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in ...

SAN DIEGO, CA / ACCESS Newswire / January 22, 2025 / Dermata Therapeutics, Inc. (NASDAQ:DRMA)(NASDAQ:DRMAW) ("Dermata," or the "Company"), a late-stage biotechnology company focused on the treatment ...